A condition affecting 170 million women worldwide, previously known as polycystic ovary syndrome (PCOS), has been renamed polyendocrine metabolic ovarian syndrome (PMOS). The name change is intended to improve diagnosis and care, reflecting the condition's metabolic and endocrine features. The renaming appears to have been made with global consensus, with experts suggesting it could lead to better care for those affected.